UniProt ID | HSP76_HUMAN | |
---|---|---|
UniProt AC | P17066 | |
Protein Name | Heat shock 70 kDa protein 6 | |
Gene Name | HSPA6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 643 | |
Subcellular Localization | ||
Protein Description | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. [PubMed: 26865365] | |
Protein Sequence | MQAPRELAVGIDLGTTYSCVGVFQQGRVEILANDQGNRTTPSYVAFTDTERLVGDAAKSQAALNPHNTVFDAKRLIGRKFADTTVQSDMKHWPFRVVSEGGKPKVRVCYRGEDKTFYPEEISSMVLSKMKETAEAYLGQPVKHAVITVPAYFNDSQRQATKDAGAIAGLNVLRIINEPTAAAIAYGLDRRGAGERNVLIFDLGGGTFDVSVLSIDAGVFEVKATAGDTHLGGEDFDNRLVNHFMEEFRRKHGKDLSGNKRALRRLRTACERAKRTLSSSTQATLEIDSLFEGVDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDVVLVGGSTRIPKVQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAVLMGDKCEKVQDLLLLDVAPLSLGLETAGGVMTTLIQRNATIPTKQTQTFTTYSDNQPGVFIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILSVTATDRSTGKANKITITNDKGRLSKEEVERMVHEAEQYKAEDEAQRDRVAAKNSLEAHVFHVKGSLQEESLRDKIPEEDRRKMQDKCREVLAWLEHNQLAEKEEYEHQKRELEQICRPIFSRLYGGPGVPGGSSCGTQARQGDPSTGPIIEEVD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | AVGIDLGTTYSCVGV EECEECCCCEEEEEE | 29.83 | - | |
17 | Phosphorylation | GIDLGTTYSCVGVFQ CEECCCCEEEEEEEE | 10.42 | - | |
39 | Phosphorylation | ANDQGNRTTPSYVAF ECCCCCCCCCCEEEE | 47.24 | 21945579 | |
40 | Phosphorylation | NDQGNRTTPSYVAFT CCCCCCCCCCEEEEE | 13.65 | 21945579 | |
42 | Phosphorylation | QGNRTTPSYVAFTDT CCCCCCCCEEEEECH | 30.10 | 21945579 | |
43 | Phosphorylation | GNRTTPSYVAFTDTE CCCCCCCEEEEECHH | 9.30 | 21945579 | |
47 | Phosphorylation | TPSYVAFTDTERLVG CCCEEEEECHHHHHH | 32.07 | 21945579 | |
49 | Phosphorylation | SYVAFTDTERLVGDA CEEEEECHHHHHHHH | 21.68 | 21945579 | |
51 | Methylation | VAFTDTERLVGDAAK EEEECHHHHHHHHHH | 36.44 | - | |
58 | Ubiquitination | RLVGDAAKSQAALNP HHHHHHHHHCHHHCC | 44.83 | - | |
59 | Phosphorylation | LVGDAAKSQAALNPH HHHHHHHHCHHHCCC | 21.96 | 24719451 | |
73 | Ubiquitination | HNTVFDAKRLIGRKF CCCHHHHHHHHCCCC | 49.97 | - | |
79 | Ubiquitination | AKRLIGRKFADTTVQ HHHHHCCCCCCCCCC | 39.42 | - | |
90 | Ubiquitination | TTVQSDMKHWPFRVV CCCCCCCCCCCEEEE | 47.73 | - | |
102 | Ubiquitination | RVVSEGGKPKVRVCY EEEEECCCCCEEEEE | 53.15 | - | |
102 | Acetylation | RVVSEGGKPKVRVCY EEEEECCCCCEEEEE | 53.15 | - | |
104 | Ubiquitination | VSEGGKPKVRVCYRG EEECCCCCEEEEECC | 46.27 | - | |
114 | Ubiquitination | VCYRGEDKTFYPEEI EEECCCCCCCCHHHH | 35.91 | - | |
115 | Phosphorylation | CYRGEDKTFYPEEIS EECCCCCCCCHHHHH | 40.50 | 20860994 | |
117 | Phosphorylation | RGEDKTFYPEEISSM CCCCCCCCHHHHHHH | 18.24 | 29438985 | |
123 | Phosphorylation | FYPEEISSMVLSKMK CCHHHHHHHHHHHHH | 20.69 | - | |
127 | Phosphorylation | EISSMVLSKMKETAE HHHHHHHHHHHHHHH | 21.20 | 29438985 | |
128 | Ubiquitination | ISSMVLSKMKETAEA HHHHHHHHHHHHHHH | 50.24 | - | |
130 | Ubiquitination | SMVLSKMKETAEAYL HHHHHHHHHHHHHHC | 56.50 | - | |
136 | Nitrated tyrosine | MKETAEAYLGQPVKH HHHHHHHHCCCCCEE | 11.67 | - | |
142 | Ubiquitination | AYLGQPVKHAVITVP HHCCCCCEEEEEEEE | 32.31 | - | |
142 | Methylation | AYLGQPVKHAVITVP HHCCCCCEEEEEEEE | 32.31 | 23644510 | |
151 | Phosphorylation | AVITVPAYFNDSQRQ EEEEEECCCCHHHCH | 9.24 | - | |
155 | Phosphorylation | VPAYFNDSQRQATKD EECCCCHHHCHHHCC | 28.50 | 17525332 | |
161 | Ubiquitination | DSQRQATKDAGAIAG HHHCHHHCCCCHHCC | 48.90 | - | |
179 | Phosphorylation | LRIINEPTAAAIAYG HHHCCCHHHHHHHHC | 23.81 | 28152594 | |
185 | Phosphorylation | PTAAAIAYGLDRRGA HHHHHHHHCCCCCCC | 16.47 | 28152594 | |
224 | Phosphorylation | GVFEVKATAGDTHLG CEEEEEECCCCCCCC | 26.00 | 29396449 | |
259 | Ubiquitination | GKDLSGNKRALRRLR CCCCCCCHHHHHHHH | 42.44 | - | |
267 | Phosphorylation | RALRRLRTACERAKR HHHHHHHHHHHHHHH | 40.01 | 27273156 | |
275 | Phosphorylation | ACERAKRTLSSSTQA HHHHHHHHHCCCCCE | 30.22 | - | |
278 | Phosphorylation | RAKRTLSSSTQATLE HHHHHHCCCCCEEHH | 40.28 | - | |
298 | Phosphorylation | EGVDFYTSITRARFE CCCCCCHHHHHHHHH | 15.58 | 20860994 | |
300 | Phosphorylation | VDFYTSITRARFEEL CCCCHHHHHHHHHHH | 20.31 | 20860994 | |
309 | Phosphorylation | ARFEELCSDLFRSTL HHHHHHHHHHHHHCC | 50.39 | 21712546 | |
314 | Phosphorylation | LCSDLFRSTLEPVEK HHHHHHHHCCHHHHH | 29.97 | - | |
315 | Phosphorylation | CSDLFRSTLEPVEKA HHHHHHHCCHHHHHH | 30.77 | 21712546 | |
321 | Ubiquitination | STLEPVEKALRDAKL HCCHHHHHHHHHCCC | 53.61 | 21890473 | |
321 | Acetylation | STLEPVEKALRDAKL HCCHHHHHHHHHCCC | 53.61 | 22640907 | |
327 | Ubiquitination | EKALRDAKLDKAQIH HHHHHHCCCCHHHCC | 62.60 | 21890473 | |
330 | Ubiquitination | LRDAKLDKAQIHDVV HHHCCCCHHHCCEEE | 53.26 | - | |
330 | Methylation | LRDAKLDKAQIHDVV HHHCCCCHHHCCEEE | 53.26 | - | |
330 | Acetylation | LRDAKLDKAQIHDVV HHHCCCCHHHCCEEE | 53.26 | - | |
347 | Ubiquitination | GGSTRIPKVQKLLQD CCCCCCHHHHHHHHH | 55.73 | - | |
350 | Ubiquitination | TRIPKVQKLLQDFFN CCCHHHHHHHHHHHC | 54.90 | 21890473 | |
350 | Acetylation | TRIPKVQKLLQDFFN CCCHHHHHHHHHHHC | 54.90 | 25953088 | |
359 | Ubiquitination | LQDFFNGKELNKSIN HHHHHCCCCCCCCCC | 61.20 | 21890473 | |
359 | Acetylation | LQDFFNGKELNKSIN HHHHHCCCCCCCCCC | 61.20 | 24513421 | |
359 | Sumoylation | LQDFFNGKELNKSIN HHHHHCCCCCCCCCC | 61.20 | - | |
363 | Ubiquitination | FNGKELNKSINPDEA HCCCCCCCCCCHHHH | 66.39 | - | |
363 | Sumoylation | FNGKELNKSINPDEA HCCCCCCCCCCHHHH | 66.39 | - | |
364 | Phosphorylation | NGKELNKSINPDEAV CCCCCCCCCCHHHHH | 26.90 | 25159151 | |
373 | Phosphorylation | NPDEAVAYGAAVQAA CHHHHHHHHHHHHHH | 10.74 | 18669648 | |
386 | Ubiquitination | AAVLMGDKCEKVQDL HHHHCCCCCCHHHHE | 38.27 | - | |
402 | Phosphorylation | LLDVAPLSLGLETAG EEECCCCCCCCCCCC | 21.23 | - | |
407 | Phosphorylation | PLSLGLETAGGVMTT CCCCCCCCCCHHHHH | 35.33 | - | |
414 | Phosphorylation | TAGGVMTTLIQRNAT CCCHHHHHHHHCCCC | 12.08 | 21601212 | |
424 | Phosphorylation | QRNATIPTKQTQTFT HCCCCCCCCCEEEEE | 31.75 | 21601212 | |
429 | Phosphorylation | IPTKQTQTFTTYSDN CCCCCEEEEEEECCC | 26.74 | - | |
433 | Phosphorylation | QTQTFTTYSDNQPGV CEEEEEEECCCCCEE | 15.80 | - | |
453 | Ubiquitination | EGERAMTKDNNLLGR ECCCCCCCCCCEECC | 45.43 | 21890473 | |
460 | Methylation | KDNNLLGRFELSGIP CCCCEECCEEECCCC | 23.10 | - | |
471 | Methylation | SGIPPAPRGVPQIEV CCCCCCCCCCCEEEE | 61.93 | 18600857 | |
479 | Phosphorylation | GVPQIEVTFDIDANG CCCEEEEEEEECCCC | 11.64 | 15302935 | |
495 | Methylation | LSVTATDRSTGKANK EEEEEEECCCCCCCE | 31.59 | 115384363 | |
497 | Phosphorylation | VTATDRSTGKANKIT EEEEECCCCCCCEEE | 43.53 | - | |
499 | Ubiquitination | ATDRSTGKANKITIT EEECCCCCCCEEEEE | 49.20 | - | |
502 | Ubiquitination | RSTGKANKITITNDK CCCCCCCEEEEECCC | 46.19 | 21890473 | |
502 | Acetylation | RSTGKANKITITNDK CCCCCCCEEEEECCC | 46.19 | 22640903 | |
504 | Phosphorylation | TGKANKITITNDKGR CCCCCEEEEECCCCC | 24.29 | 25159151 | |
509 | Sumoylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | - | |
509 | Ubiquitination | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | 21890473 | |
509 | Sumoylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | - | |
509 | Acetylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | 83037561 | |
513 | Phosphorylation | TNDKGRLSKEEVERM ECCCCCCCHHHHHHH | 36.34 | 26091039 | |
514 | Ubiquitination | NDKGRLSKEEVERMV CCCCCCCHHHHHHHH | 63.59 | - | |
528 | Ubiquitination | VHEAEQYKAEDEAQR HHHHHHHHHHCHHHH | 45.02 | - | |
541 | Ubiquitination | QRDRVAAKNSLEAHV HHHHHHHHHHHHEEE | 37.01 | - | |
552 | Ubiquitination | EAHVFHVKGSLQEES HEEEEEECCCCCHHH | 33.92 | - | |
563 | "N6,N6,N6-trimethyllysine" | QEESLRDKIPEEDRR CHHHHHHHCCHHHHH | 54.44 | - | |
563 | Ubiquitination | QEESLRDKIPEEDRR CHHHHHHHCCHHHHH | 54.44 | - | |
563 | Methylation | QEESLRDKIPEEDRR CHHHHHHHCCHHHHH | 54.44 | 23921388 | |
591 | Ubiquitination | EHNQLAEKEEYEHQK HHHHHHCHHHHHHHH | 50.68 | - | |
598 | Ubiquitination | KEEYEHQKRELEQIC HHHHHHHHHHHHHHH | 50.15 | - | |
626 | Phosphorylation | PGGSSCGTQARQGDP CCCCCCCCCCCCCCC | 24.31 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HSP76_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HSP76_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HSP76_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SCFD1_HUMAN | SCFD1 | physical | 22939629 | |
HSP7C_HUMAN | HSPA8 | physical | 22863883 | |
DNJA1_HUMAN | DNAJA1 | physical | 21231916 | |
DNJA2_HUMAN | DNAJA2 | physical | 21231916 | |
DNJA4_HUMAN | DNAJA4 | physical | 21231916 | |
DNJB1_HUMAN | DNAJB1 | physical | 21231916 | |
DNJB4_HUMAN | DNAJB4 | physical | 21231916 | |
DNJB5_HUMAN | DNAJB5 | physical | 21231916 | |
DNJB6_HUMAN | DNAJB6 | physical | 21231916 | |
DNJB7_HUMAN | DNAJB7 | physical | 21231916 | |
DNJB8_HUMAN | DNAJB8 | physical | 21231916 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-321 AND LYS-502, AND MASSSPECTROMETRY. |